drug protocol number

NN9536-7752

drug sponsor

Novo Nordisk

drug study

Semaglutide

drug trial site

King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Riyadh) ,King Abdulaziz Hospital NG (Al Ahsa), King Abdulaziz Medical City NG (Jeddah) ,King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase